Full Text (PDF)
Original Article

PAP-Smear Study and its Utility in Cervical Cancer Screening in A Tertiary Care Hospital: An Institutional Based Study

Punam Prasad Bhadani, Additional Prof. and Head, Department of Pathology, All India Institute of Medical Sciences, Phulwari Sharif, Patna, Bihar 801507, India. , Punam Prasad Bhadani* , Iffat Jamal** , Shuchismita*** , Suryakant Nirala**** , Shashikant Kumar*****

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 7(1):p 12-16, January 2018. | DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.7118.2

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Cancer of uterine cervix is a leading cause of mortality and morbidity among women worldwide Papanicolaou cytological (Pap) test is, in many respects, the ideal screening test. Cervical cancer has a defined premalignant phase of many years, which allows repeated tests to significantly reduce the impact of individual false negative test results. Cervical cytology is inexpensive and readily accepted among Indian women.This is a retrospective study aimed to evaluate all previously conducted cervical smears examined at a teaching tertiary hospital during a two and half year period to find out the prevalence of abnormal pap smears. Materials & Methods: Detailed clinical data and Pap smear cytology reports were obtained from June 2014 to December 2016 and data noted in a structured Performa. All the smears were reported as per the revised 2014 Bethesda system. Prevalence of epithelial abnormalities was calculated in percentages. Results: Out of 1671 cases, 1635(97.8%) were negative for intraepithelial lesion/malignancy, 36 cases (2.15%) were positive for intraepithelial lesion. Conclusion: Pap smear provides supportive evidence as a tool for screening for cervical cancer. There is a need to increase the awareness among women to know the utility of this test to prevent precancerous changes in cervix can be detected before they progress to frank malignancy.

Keywords: Cervical Cancer; Screening; Bethesda System; Pap Smear; Papanicolaou. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.7118.2

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 14:54:31 (IST)


2018

Accesses

3
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share